Molecular psychiatry · 2026
BDNF restores impaired long-term potentiation of GABAergic synapses induced by chronic ethanol exposure in the VTA and attenuates reward-seeking behavior.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xiong Jun-Wei, Dou Meng-Yao, Wang Ying, Zeng Ting, Qi Xunzhong, Wei Jia-Ning, Shi Xiao-Wei, Cui Dan-Dan, Dai Hui-Zhen, Du Chen-Yu, Xu Xiang-Min, Wang Xiao-Fei, Zhu Xiaofeng, Guan Yanzhong
Аннотация
Cellular and synaptic plasticity in ventral tegmental area (VTA) play a key role in alcohol use disorder (AUD). Here, we first delineated the in vivo dynamics of dopamine (DA) neuron activity in VTA during chronic intermittent ethanol exposure: initial sensitization was followed by a phase of attenuated and dysregulated response upon the first high-concentration exposure, culminating in stable hyper-responsiveness. Chronic ethanol exposure impaired long-term potentiation of GABAergic synapses (LTPGABA) on VTA DA neurons by reducing presynaptic GABA release, and induced lower levels of brain-derived neurotrophic factor (BDNF) expression in VTA. The impaired LTPGABA recovered after 7 days of withdrawal, in parallel with a restoration of BDNF expression in the VTA. Using a combination of pharmacological and region-specific genetic knockdown approaches, we demonstrate that BDNF signaling through its receptor TrkB is both necessary and sufficient for LTPGABA induction. Crucially, in VTA slices from chronic ethanol-exposed mice, BDNF application rescued the impaired LTPGABA. In vivo, microinjection of BDNF into the VTA rapidly restored the hyperactive state of DA neuron activity induced by ethanol consumption (6 mice per group), an effect that was mimicked by the GABAA receptor agonist muscimol and blocked by co-administration of either the TrkB antagonist K252a or the GABAA receptor antagonist Gabazine. Furthermore, BDNF microinjection significantly attenuated cue-driven ethanol-seeking behavior (reducing the progressive ratio breakpoint by 52%; 6 mice per group), an effect depending on TrkB activation. Together, our findings reveal that chronic ethanol exposure impairs GABAergic plasticity via BDNF-TrkB signaling, while BDNF restores the impaired LTPGABA and dynamics of DA neuron activity, and attenuates ethanol seeking, identifying a novel therapeutic target for AUD.